Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease
Year: 2006
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Institutions: Duke Clinical Research Institute, Columbia University Irving Medical Center, Cardiovascular Research Foundation, Brigham and Women's Hospital, Baim Institute for Clinical Research, Stanford Medicine, St Vincent Hospital, Washington Adventist Hospital, Atrium Health Wake Forest Baptist, Sinai Hospital, St. Joseph Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: zotarolimus-eluting stent, sirolimus-eluting stent, native coronary artery disease, coronary stenting, late lumen loss, in-segment restenosis, target lesion revascularization, target vessel failure, major adverse cardiac events, phosphorylcholine polymers, percutaneous coronary intervention, de novo coronary lesions, stent safety and efficacy, Endeavor
Open Access status: bronze
OpenAlex ID: W105018345
